These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and Epidemiologic Profile of Invasive Pneumococcal Disease in Australian Children Following the Relaxation of Nonpharmaceutical Interventions Against SARS-COV-2. Williams PCM; Howard-Jones A; Butters C; Koirala A; Britton PN; Duguid R; Wijeratne P; Johnson N; Jayasinghe S Pediatr Infect Dis J; 2023 Sep; 42(9):e341-e342. PubMed ID: 37200512 [TBL] [Abstract][Full Text] [Related]
3. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France. Rybak A; Levy C; Angoulvant F; Auvrignon A; Gembara P; Danis K; Vaux S; Levy-Bruhl D; van der Werf S; Béchet S; Bonacorsi S; Assad Z; Lazzati A; Michel M; Kaguelidou F; Faye A; Cohen R; Varon E; Ouldali N JAMA Netw Open; 2022 Jun; 5(6):e2218959. PubMed ID: 35763298 [TBL] [Abstract][Full Text] [Related]
4. Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England. Bertran M; Amin-Chowdhury Z; Sheppard CL; Eletu S; Zamarreño DV; Ramsay ME; Litt D; Fry NK; Ladhani SN Emerg Infect Dis; 2022 Aug; 28(8):1669-1672. PubMed ID: 35876698 [TBL] [Abstract][Full Text] [Related]
5. Vaccine Failures in Patients Properly Vaccinated with 13-Valent Pneumococcal Conjugate Vaccine in Catalonia, a Region with Low Vaccination Coverage. Moraga-Llop F; Garcia-Garcia JJ; Díaz-Conradi A; Ciruela P; Martínez-Osorio J; González-Peris S; Hernández S; de Sevilla MF; Uriona S; Izquierdo C; Selva L; Campins M; Codina G; Batalla J; Esteva C; Domínguez À; Muñoz-Almagro C Pediatr Infect Dis J; 2016 Apr; 35(4):460-3. PubMed ID: 26658626 [TBL] [Abstract][Full Text] [Related]
6. Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2-59 Months of Age, Spain. Hernández S; Moraga-Llop F; Díaz A; de Sevilla MF; Ciruela P; Muñoz-Almagro C; Codina G; Campins M; García-García JJ; Esteva C; Izquierdo C; González-Peris S; Martínez-Osorio J; Uriona S; Salleras L; Domínguez Á Emerg Infect Dis; 2020 Jun; 26(6):1147-1155. PubMed ID: 32441620 [TBL] [Abstract][Full Text] [Related]
7. Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study. Danino D; Ben-Shimol S; van der Beek BA; Givon-Lavi N; Avni YS; Greenberg D; Weinberger DM; Dagan R Clin Infect Dis; 2022 Aug; 75(1):e1154-e1164. PubMed ID: 34904635 [TBL] [Abstract][Full Text] [Related]
8. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. Muñoz-Almagro C; Ciruela P; Esteva C; Marco F; Navarro M; Bartolome R; Sauca G; Gallés C; Morta M; Ballester F; Raga X; Selva L; J Infect; 2011 Aug; 63(2):151-62. PubMed ID: 21679725 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness. Ochoa-Gondar O; Figuerola-Massana E; Vila-Corcoles A; Aguirre CA; de Diego C; Satue E; Gomez F; Raga X; Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2104-8. PubMed ID: 26453272 [TBL] [Abstract][Full Text] [Related]
10. Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods. Hernández S; Muñoz-Almagro C; Ciruela P; Soldevila N; Izquierdo C; Codina MG; Díaz A; Moraga-Llop F; García-García JJ; Domínguez Á J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189583 [TBL] [Abstract][Full Text] [Related]
11. Increase of Macrolide-Resistance in Gonzales BE; Mercado EH; Pinedo-Bardales M; Hinostroza N; Campos F; Chaparro E; Del Águila O; Castillo ME; Saenz A; Reyes I; Ochoa TJ Front Cell Infect Microbiol; 2022; 12():866186. PubMed ID: 35615398 [No Abstract] [Full Text] [Related]
12. Age-Specific Resurgence in Invasive Pneumococcal Disease Incidence in the COVID-19 Pandemic Era and Its Association With Respiratory Virus and Pneumococcal Carriage Dynamics: A Time-Series Analysis. Rybak A; Assad Z; Levy C; Bonarcorsi S; Béchet S; Werner A; Wollner A; Valtuille Z; Kaguelidou F; Angoulvant F; Cohen R; Varon E; Ouldali N Clin Infect Dis; 2024 Apr; 78(4):855-859. PubMed ID: 38059538 [TBL] [Abstract][Full Text] [Related]
13. Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract. Lewnard JA; Bruxvoort KJ; Fischer H; Hong VX; Grant LR; Jódar L; Gessner BD; Tartof SY J Infect Dis; 2022 May; 225(10):1710-1720. PubMed ID: 33693636 [TBL] [Abstract][Full Text] [Related]
14. Serotype distribution of Streptococcus pneumoniae isolated from children hospitalized in Beijing children's hospital (2013-2019). Wang Q; Shi W; Li Y; Gao W; Yuan L; Dong F; Yao K Vaccine; 2020 Nov; 38(49):7858-7864. PubMed ID: 33164807 [TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 Nonpharmaceutical Interventions on Pneumococcal Carriage Prevalence and Density in Vietnam. Nation ML; Manna S; Tran HP; Nguyen CD; Vy LTT; Uyen DY; Phuong TL; Dai VTT; Ortika BD; Wee-Hee AC; Beissbarth J; Hinds J; Bright K; Smith-Vaughan H; Nguyen TV; Mulholland K; Temple B; Satzke C Microbiol Spectr; 2023 Feb; 11(1):e0361522. PubMed ID: 36645282 [TBL] [Abstract][Full Text] [Related]
16. Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands. Knol MJ; Wagenvoort GH; Sanders EA; Elberse K; Vlaminckx BJ; de Melker HE; van der Ende A Emerg Infect Dis; 2015 Nov; 21(11):2040-4. PubMed ID: 26488415 [TBL] [Abstract][Full Text] [Related]
17. Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era. de Miguel S; Domenech M; González-Camacho F; Sempere J; Vicioso D; Sanz JC; Comas LG; Ardanuy C; Fenoll A; Yuste J Clin Infect Dis; 2021 Dec; 73(11):e3778-e3787. PubMed ID: 32990303 [TBL] [Abstract][Full Text] [Related]
18. Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13. Redin A; Ciruela P; de Sevilla MF; Gomez-Bertomeu F; Gonzalez-Peris S; Benitez MA; Trujillo G; Diaz A; Jou E; Izquierdo C; Perez-Moreno MO; Moraga-Llop F; Olsina M; Vinado B; Sanfeliu E; Garcia A; Gonzalez-di Lauro S; Garcia-Garcia JJ; Dominguez A; Sa-Leao R; Muñoz-Almagro C; Microbiol Spectr; 2021 Dec; 9(3):e0115021. PubMed ID: 34878302 [TBL] [Abstract][Full Text] [Related]
19. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. von Kries R; Hermann M; Hachmeister A; Siedler A; Schmitt HJ; Al-Lahham A; Reinert RR Pediatr Infect Dis J; 2002 Nov; 21(11):1017-23. PubMed ID: 12442022 [TBL] [Abstract][Full Text] [Related]
20. [Epidemiology of invasive pneumococcal disease in Tarragona, Spain, 2012-2015: incidence, lethality and serotype-coverage for distinct antipneumococcal vaccine formulations]. Vila Córcoles Á; Dacosta Moreira C; de Diego Cabanes C; Ochoa Gondar O; Raga Gutiérrez M; Gómez Bertomeu F; Raga Luria X; Figuerola Massana E Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30280720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]